Market Snapshot
S&P Futures
3,914.75
Dow Futures
31,478
Nasdaq Futures
12,132.75
AIkido Pharma Inc. (AIKI) stock declined over -1.39% intraday to trade at $5.66 a share on NASDAQ. The stock opened with a gain of 1.98% at $5.81 and touched an intraday high of $5.93, falling -1.39% against the last close of $5.74. The stock went to a low of $5.4 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-06-23 | $5.81 | $5.93 | $5.4 | $5.66 | 144,300 |
2022-06-22 | $5.55 | $5.92 | $5.55 | $5.74 | 144,300 |
2022-06-21 | $5.47 | $5.76 | $5.37 | $5.57 | 134,300 |
2022-06-17 | $5.32 | $5.66 | $5.28 | $5.46 | 103,200 |
2022-06-16 | $5.36 | $5.52 | $5.14 | $5.19 | 57,500 |
2022-06-15 | $5.26 | $5.66 | $5.22 | $5.48 | 141,800 |
2022-06-14 | $5.12 | $5.43 | $5.12 | $5.28 | 89,700 |
2022-06-13 | $5.01 | $5.26 | $4.96 | $5.15 | 109,500 |
2022-06-10 | $5.25 | $5.32 | $5.17 | $5.23 | 63,700 |
2022-06-09 | $5 | $5.43 | $5 | $5.41 | 102,400 |
Employees-
Beta1.43
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York.
AIkido Pharma Inc. (NASDAQ: AIKI) stock price is $5.66 as of the last check on Thursday, June 23. During the trading session, AIKI stock reached the peak price of $5.93 while $5.4 was the lowest point it dropped to.
The NASDAQ listed AIKI is part of Biotechnology industry that operates in the broader Health Care sector. AIkido Pharma Inc. , a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics.
Mr. Anthony C. Hayes Esq.
CEO, Principal Financial Officer, Principal Accounting Officer & Director
Mr. Darrell Dotson
VP of Drug Devel. & Gen. Counsel
AIKI stock traded closed the last session at $5.66, which is $-0.08 or -1.39% lower than its previous close of $5.74. AIKI's current trading price is 31.63% lower than its 52-week high of $20.57 where as its distance from 52-week low of 4.30% is -72.48%.
Number of AIKI employees currently stands at -. AIKI operates from One Rockefeller Plaza, 11th Floor, New York, NY 10020, United States.
Official Webiste of $AIKI is: https://www.aikidopharma.com
AIKI could be contacted at AIKI operates from One Rockefeller Plaza, 11th Floor, New York, NY 10020, United States, or at phone #703 992 9325 and can also be accessed through its website.
AIKI stock volume for the day was 144,322 shares while in the previous session number of AIKI shares traded was 144,300 . The average number of AIKI shares traded daily for last 3 months was 121.06 Thousands.
The percentage change in AIKI stock occurred in the recent session was -1.39% while the dollar amount for the price change in AIKI stock was $-0.08.
In the recent session, the day high for AIKI stock was $5.93 while the low for AIKI stock touched on the day was $5.4.
The market value of AIKI currently stands at 28.3 Million with its latest stock price at $5.66 and 5.25 Million of its shares outstanding.